Frontiers Lu-177-PSMA dosimetry for kidneys and tumors based on

$ 21.50

4.6 (683) In stock

Frontiers Current role of prostate-specific membrane antigen-based imaging and radioligand therapy in castration-resistant prostate cancer

EAU 2023: LuTectomy: A Prospective Study of Dosimetry, Safety and

Frontiers Towards Routine Clinical Use of Dosimetry in [177Lu]Lu

Theranostics and artificial intelligence: new frontiers in

How We Do It: A Multidisciplinary Approach to 177Lu DOTATATE

PDF) Towards Single Time Point Image-Based Dosimetry of 177 Lu

Frontiers Lu-177-PSMA dosimetry for kidneys and tumors based on

Frontiers 177Lu-labeled PSMA targeting therapeutic with

Feasibility of single time point image-based dosimetry using prior

Figure 5 from Lu-177-PSMA-617 Prostate-Specific Membrane Antigen

Simplified dosimetry for kidneys and tumors in 177Lu-labeled